Get the latest news on Getinge stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on GNGBF performance

Latest Getinge Stock News | OTC:GNGBF | Benzinga

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.

Getinge AB

Small Cap

Press Releases

Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average

Earnings

Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers

Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Getinge completes the acquisition of Paragonix Technologies

Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

Getinge Year End Report 2024: Strong order intake and increased sales contributed to sharp improvement in margins

GNGBF

GNGBY

Getinge

Comments

Getinge Stock News

News

Latest Getinge Stock News | OTC:GNGBF | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga